	US 12,247,199 B2
	Nucleic acid elution
Andrew Francis Page, Wilmington, DE (US); and Breck Olland Parker, Sanford, ME (US)
Assigned to Global Life Sciences Solutions USA LLC, Marlborough, MA (US)
Filed by Global Life Sciences Solutions USA LLC, Marlborough, MA (US)
Filed on Jun. 23, 2023, as Appl. No. 18/340,609.
Application 18/340,609 is a division of application No. 17/122,606, filed on Dec. 15, 2020, granted, now 11,725,201.
Application 17/122,606 is a division of application No. 13/519,391, abandoned, previously published as PCT/EP2010/070389, filed on Dec. 21, 2010.
Claims priority of provisional application 61/290,652, filed on Dec. 29, 2009.
Prior Publication US 2023/0332133 A1, Oct. 19, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 15/10 (2006.01); C12Q 1/6806 (2018.01)

CPC C12N 15/1003 (2013.01) [C12Q 1/6806 (2013.01)]

14 Claims

1. A composition for the storage of a purified nucleic acid, the composition consisting of:

a solid matrix,

guanidine thiocyanate,

inulin, and optionally a purified nucleic acid, a polyethylene glycol, or a buffer;

wherein the solid matrix is impregnated with the inulin and the guanidine thiocyanate.